2522 JCS Joint Working Group was required, the Japanese Circulation Society Joint
Working Groups published the Guidelines for Diagnosis and Management of Cardiovascular …

BACKGROUND: Neonatal arterial ischemic stroke (AIS) has emerged as a leading cause of
perinatal brain injury, cerebral palsy, and lifelong disability. The pathogenesis is poorly …

Cerebral venous sinus (sinovenous) thrombosis (CSVT) is an increasingly recognized
cause of childhood and neonatal stroke. Recent developments in the field highlight the …

The optimal management of asparaginase‐associated thrombotic complications is not well‐
defined. We report the features, management and outcome of paediatric (ages 0–18 years) …

Background Treatment of cerebral venous sinus thrombosis with anticoagulants has been
controversial. Anticoagulants may prevent new venous infarcts, neurologic deterioration and …

Objective Clinical trials are lacking in pediatric cerebral sinovenous thrombosis (CSVT).
Neonates and children increasingly receive anticoagulant therapy (ACT) based on adult …

Background and Purpose—Cerebral sinovenous thrombosis is a rare disease with severe
neurological sequelae. The aim of this retrospective multicenter study was to investigate the …

Background For childhood-onset arterial ischaemic stroke (AIS), treatment trials are lacking
and practices vary from country to country and centre to centre. We aimed to describe …

Background The safety and efficacy of thrombolysis after acute stroke in children have not
been established. Our aim was to describe current practices and results of the use of …

With an incidence of 1/2800 to 1/5000 live-births, perinatal arterial ischemic stroke is the
most frequent form of cerebral infarction in children. About 40% of the children do not have …